ITGB4 and hepatocellular carcinoma: Consistently, increased expression of both ITGB1 and ITGB4 were associated with shorter overall survival (OS), relapse‐free survival (RFS), and progression‐free survival (PFS) of HCC patients (Figure S10B, Supporting Information).